Max Spaderna MD, Elana Rosenthal MD, Sun Jung Kang PhD, Rahwa Eyasu MSN, FNP, Emade Ebah MPH, Onyinyechi Ogbumbadiugha MPH, Phyllis Bijole MA, Amelia Cover CRNP, Ashley Davis CRNP, Meredith Zoltick MSN, MPH, Sita Kottilil, Julia Mount BS, Catherine Gannon BA, Jasmine Stevens BS, Grace Garrett BS, Meghan Derenoncourt BS, Tina Liu AB, Lisa Horowitz PhD, MPH, Maryland Pao MD, Sarah Kattakuzhy MD, MPH
{"title":"Elevated rate of suicide risk in individuals with opioid use disorder","authors":"Max Spaderna MD, Elana Rosenthal MD, Sun Jung Kang PhD, Rahwa Eyasu MSN, FNP, Emade Ebah MPH, Onyinyechi Ogbumbadiugha MPH, Phyllis Bijole MA, Amelia Cover CRNP, Ashley Davis CRNP, Meredith Zoltick MSN, MPH, Sita Kottilil, Julia Mount BS, Catherine Gannon BA, Jasmine Stevens BS, Grace Garrett BS, Meghan Derenoncourt BS, Tina Liu AB, Lisa Horowitz PhD, MPH, Maryland Pao MD, Sarah Kattakuzhy MD, MPH","doi":"10.1111/ajad.70027","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background and Objectives</h3>\n \n <p>Few studies have longitudinally investigated suicide risk (SR) in opioid use disorder (OUD). This investigation administered three screening tools to individuals with OUD to compare rates of and variables associated with SR over 12 months.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>121 individuals meeting criteria for OUD within the past 3 years were administered Item #9 of Patient Health Questionnaire-9 (PHQ-Item-9), the twelfth item of DSM-5-TR Self-Rated Level 1 Cross-Cutting Measure (CCSM-Item-12), and the Ask Suicide-Screening Questions (ASQ) to detect SR at Day 0 and Months 6 and 12. A partitioned generalized methods of moment (GMM) model identified variables associated with SR.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>At Day 0, screen-positive rates for SR were 30% for ASQ, 12.4% for PHQ-Item-9, and 4.1% for CCSM-Item-12. Rates were similar at Months 6 and 12. Variables significantly associated with SR by PHQ-Item-9 were intentional overdose history (<i>p</i> < .001), poor sleep (<i>p</i> < .001), meeting criteria for psychosis (<i>p</i> < .001), and meeting criteria for mania (<i>p</i> = .005). Variables significantly associated with SR by ASQ were intentional overdose history (<i>p</i> < .001), female gender (<i>p</i> = .003), meeting criteria for psychosis (<i>p</i> = .001), and total PHQ-9 score (<i>p</i> = .032). Too few participants endorsed SR by CCSM-Item-12 to be included.</p>\n </section>\n \n <section>\n \n <h3> Discussion and Conclusions</h3>\n \n <p>In the OUD population, screening positive for SR was unchanged over 1 year, but detection rates varied by screening tool. History of intentional opioid overdose is independently associated with screening positive for SR.</p>\n </section>\n \n <section>\n \n <h3> Scientific Significance</h3>\n \n <p>This is the first study to evaluate SR in the OUD population using more than one screening tool, and to show an association of history of intentional opioid overdose with SR.</p>\n </section>\n </div>","PeriodicalId":7762,"journal":{"name":"American Journal on Addictions","volume":"34 4","pages":"440-449"},"PeriodicalIF":2.5000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajad.70027","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal on Addictions","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ajad.70027","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0
Abstract
Background and Objectives
Few studies have longitudinally investigated suicide risk (SR) in opioid use disorder (OUD). This investigation administered three screening tools to individuals with OUD to compare rates of and variables associated with SR over 12 months.
Methods
121 individuals meeting criteria for OUD within the past 3 years were administered Item #9 of Patient Health Questionnaire-9 (PHQ-Item-9), the twelfth item of DSM-5-TR Self-Rated Level 1 Cross-Cutting Measure (CCSM-Item-12), and the Ask Suicide-Screening Questions (ASQ) to detect SR at Day 0 and Months 6 and 12. A partitioned generalized methods of moment (GMM) model identified variables associated with SR.
Results
At Day 0, screen-positive rates for SR were 30% for ASQ, 12.4% for PHQ-Item-9, and 4.1% for CCSM-Item-12. Rates were similar at Months 6 and 12. Variables significantly associated with SR by PHQ-Item-9 were intentional overdose history (p < .001), poor sleep (p < .001), meeting criteria for psychosis (p < .001), and meeting criteria for mania (p = .005). Variables significantly associated with SR by ASQ were intentional overdose history (p < .001), female gender (p = .003), meeting criteria for psychosis (p = .001), and total PHQ-9 score (p = .032). Too few participants endorsed SR by CCSM-Item-12 to be included.
Discussion and Conclusions
In the OUD population, screening positive for SR was unchanged over 1 year, but detection rates varied by screening tool. History of intentional opioid overdose is independently associated with screening positive for SR.
Scientific Significance
This is the first study to evaluate SR in the OUD population using more than one screening tool, and to show an association of history of intentional opioid overdose with SR.
期刊介绍:
The American Journal on Addictions is the official journal of the American Academy of Addiction Psychiatry. The Academy encourages research on the etiology, prevention, identification, and treatment of substance abuse; thus, the journal provides a forum for the dissemination of information in the extensive field of addiction. Each issue of this publication covers a wide variety of topics ranging from codependence to genetics, epidemiology to dual diagnostics, etiology to neuroscience, and much more. Features of the journal, all written by experts in the field, include special overview articles, clinical or basic research papers, clinical updates, and book reviews within the area of addictions.